PMGC (ELAB) announced the closing of the previously announced divestiture of its 100% wholly owned subsidiary Elevai Skincare pursuant to a definitive purchase agreement with Carmell Corporation (CTCX) and reaffirms its commitment to accelerating shareholder value creation and market leadership following the sale of its skincare subsidiary, Elevai Skincare. This strategic Divestiture marks a significant milestone in PMGC’s journey as a diversified holding company.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAB:
- PMGC Holdings announces name change of wholly owned subsidiares
- Carmell Therapeutics enters definitive agreement to acquire Elevai Skincare
- Elevai Labs plans name change to PMGC Holdings, redomicile to Nevada
- Elevai Labs subsidiary announces FDA regulatory pathway for EL-22
- Elevai Skincare launches S-Series Root Renewal System